C

Cabio Biotech Wuhan Co Ltd
SSE:688089

Watchlist Manager
Cabio Biotech Wuhan Co Ltd
SSE:688089
Watchlist
Price: 19.92 CNY -0.99% Market Closed
Market Cap: 3.4B CNY

Wall Street
Price Targets

Price Targets Summary
Cabio Biotech Wuhan Co Ltd

Wall Street analysts forecast Cabio Biotech Wuhan Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Cabio Biotech Wuhan Co Ltd is 26.52 CNY with a low forecast of 26.26 CNY and a high forecast of 27.3 CNY.

Lowest
Price Target
26.26 CNY
32% Upside
Average
Price Target
26.52 CNY
33% Upside
Highest
Price Target
27.3 CNY
37% Upside
Cabio Biotech Wuhan Co Ltd Competitors:
Price Targets

Revenue
Forecast

Revenue Estimate
Cabio Biotech Wuhan Co Ltd

For the last 7 years the compound annual growth rate for Cabio Biotech Wuhan Co Ltd's revenue is 14%. The projected CAGR for the next 3 years is 13%.

14% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Cabio Biotech Wuhan Co Ltd

For the last 7 years the compound annual growth rate for Cabio Biotech Wuhan Co Ltd's operating income is 12%. The projected CAGR for the next 3 years is 34%.

12% / Year
Past Growth
34% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Cabio Biotech Wuhan Co Ltd

For the last 7 years the compound annual growth rate for Cabio Biotech Wuhan Co Ltd's net income is 10%. The projected CAGR for the next 3 years is 24%.

10% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-12%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Cabio Biotech Wuhan Co Ltd's stock price target?
Price Target
26.52 CNY

According to Wall Street analysts, the average 1-year price target for Cabio Biotech Wuhan Co Ltd is 26.52 CNY with a low forecast of 26.26 CNY and a high forecast of 27.3 CNY.

What is Cabio Biotech Wuhan Co Ltd's Revenue forecast?
Projected CAGR
13%

For the last 7 years the compound annual growth rate for Cabio Biotech Wuhan Co Ltd's revenue is 14%. The projected CAGR for the next 3 years is 13%.

What is Cabio Biotech Wuhan Co Ltd's Operating Income forecast?
Projected CAGR
34%

For the last 7 years the compound annual growth rate for Cabio Biotech Wuhan Co Ltd's operating income is 12%. The projected CAGR for the next 3 years is 34%.

What is Cabio Biotech Wuhan Co Ltd's Net Income forecast?
Projected CAGR
24%

For the last 7 years the compound annual growth rate for Cabio Biotech Wuhan Co Ltd's net income is 10%. The projected CAGR for the next 3 years is 24%.

Back to Top